Indigo Diabetes sends diabetes device to clinic

A phase I trial will investigate the Belgian company’s electronic metabolite monitoring product, which is designed to be ”inconspicuous,” reducing stigma for patients wearing visible devices.

Indigo Diabetes is clinically testing an "inconspicuous" device meant to help diabetes patients keep track of their disease | Photo: Indigo Diabtes / PR

In the future, people with diabetes might gain a discreet and less stigmatized instrument for the toolbox to help them keep track of their disease, as Indigo Diabetes has started clinically testing a new monitoring device, the Belgian medtech company announces in a press release.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs